A randomized trial of nicotine-replacement therapy patches in pregnancy.
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Nicotine-replacement therapy is effective for smoking cessation outside pregnancy and its use is widely recommended during pregnancy. We investigated the efficacy and safety of nicotine patches during pregnancy. METHODS: We recruited participants from seven hospitals in England who were 16 to 50 years of age with pregnancies of 12 to 24 weeks' gestation and who smoked five or more cigarettes per day. Participants received behavioral cessation support and were randomly assigned to 8 weeks of treatment with active nicotine patches (15 mg per 16 hours) or matched placebo patches. The primary outcome was abstinence from the date of smoking cessation until delivery, as validated by measurement of exhaled carbon monoxide or salivary cotinine. Safety was assessed by monitoring for adverse pregnancy and birth outcomes. RESULTS: Of 1050 participants, 521 were randomly assigned to nicotine-replacement therapy and 529 to placebo. There was no significant difference in the rate of abstinence from the quit date until delivery between the nicotine-replacement and placebo groups (9.4% and 7.6%, respectively; unadjusted odds ratio with nicotine-replacement therapy, 1.26; 95% confidence interval, 0.82 to 1.96), although the rate was higher at 1 month in the nicotine-replacement group than in the placebo group (21.3% vs. 11.7%). Compliance was low; only 7.2% of women assigned to nicotine-replacement therapy and 2.8% assigned to placebo used patches for more than 1 month. Rates of adverse pregnancy and birth outcomes were similar in the two groups. CONCLUSIONS: Adding a nicotine patch (15 mg per 16 hours) to behavioral cessation support for women who smoked during pregnancy did not significantly increase the rate of abstinence from smoking until delivery or the risk of adverse pregnancy or birth outcomes. However, low compliance rates substantially limited the assessment of safety. (Funded by the National Institute for Health Research Health Technology Assessment Programme; Current Controlled Trials number, ISRCTN07249128.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“All seven included RCTs (N=2,285) were designed to test the effectiveness of NRT on smoking cessation and reported infant, child, and maternal health.[93](#R93),[94](#R94),[97](#R97),[100](#R100)-[102](#R102),[104](#R104)”
From Interventions for Tobacco Cessation in Adults, Including Pregnant Persons (2021) · cites this paper as [93]
In the citing paper
“Five placebo-controlled trials reported on preterm birth (delivery at <37 weeks gestation).[93](#R93),[94](#R94),[100](#R100),[101](#R101),[104](#R104)”
From Interventions for Tobacco Cessation in Adults, Including Pregnant Persons (2021) · cites this paper as [93]
In the citing paper
“All seven trials reported the association between NRT and mean birthweight.[93](#R93),[94](#R94),[97](#R97),[100](#R100)-[102](#R102),[104](#R104)”
From Interventions for Tobacco Cessation in Adults, Including Pregnant Persons (2021) · cites this paper as [93]
In the citing paper
“Within the other trials, one (N=403) reported similar numbers of women with preterm birth in the NRT and placebo groups (14.0% vs. 13.5%, respectively),[93](#R93)”
From Interventions for Tobacco Cessation in Adults, Including Pregnant Persons (2021) · cites this paper as [93]
In the citing paper
“There was no evidence of perinatal harms related to NRT use among pregnant women, but data for assessing rare harms were very limited.”
From Interventions for Tobacco Cessation in Adults, Including Pregnant Persons (2021) · cites this paper as [93]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,464
Biochemical verification of tobacco use and cessation
Benowitz, N. L., III, P. J., Ahijevych, K., Jarvis, M. J., Hall, S., LeHouezec, J., Hansson, A., Lichtenstein, E., Henningfield, J., Tsoh, J., et al. (2002) · Nicotine & Tobacco Research · doi:10.1080/14622200210123581 · Cited by 1,800
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., RICKERT, W., & ROBINSON, J. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb03059.x · Cited by 1,313
Outcome criteria in smoking cessation trials: proposal for a common standard
West, R., Hajek, P., Stead, L., & Stapleton, J. (2005) · Addiction · doi:10.1111/j.1360-0443.2004.00995.x · Cited by 1,285
Cnattingius, S. (2004) · Nicotine & Tobacco Research · doi:10.1080/14622200410001669187 · Cited by 1,126
Pocock, S. J., Assmann, S. E., Enos, L. E., & Kasten, L. E. (2002) · Statistics in Medicine · doi:10.1002/sim.1296 · Cited by 1,077
Measures of abstinence in clinical trials: issues and recommendations
Hughes, J. R., Keely, J. P., Niaura, R. S., Ossip-Klein, D. J., Richmond, R. L., & Swan, G. E. (2003) · Nicotine & Tobacco Research · doi:10.1093/ntr/5.1.13 · Cited by 1,058
Interventions for promoting smoking cessation during pregnancy
Lumley, J., Chamberlain, C., Dowswell, T., Oliver, S., Oakley, L., & Watson, L. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001055.pub3 · Cited by 890
Nicotine receptor partial agonists for smoking cessation
Hey, K., Lancaster, T., & Bala, M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103 · Cited by 861
Research works printed but not linked: 4
- Lumley J, 2009, Cochrane Database Syst Rev, 3, CD001055
- Cahill K, 2007, Cochrane Database Syst Rev, 1, CD006103
- Hughes JR, 2007, Cochrane Database Syst Rev, 1, CD000031
- Stead LF, 2008, Cochrane Database Syst Rev, 1, CD000146
Cited by
Items 101–194 of 194
Bowker, K. A., Lewis, S., Coleman, T., Vaz, L. R., & Cooper, S. (2014) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntu029 · Cited by 17
Self-citationSafety of Nicotine Replacement Therapy during Pregnancy: A Narrative Review
Morales‐Suárez‐Varela, M., Puig, B. M., Kærlev, L., Peraita‐Costa, I., & Perales, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20010250 · Cited by 18
“Nicotine patches are the most studied presentation of NRT in recent times, Coleman et al. 2012 [30] in a randomized multicenter study in which 1050 pregnant women from 12 to 24 weeks and who were smokers of at least five cigarettes per day participated.”
BackgroundMethodResultInfluentialCooper, S., Foster, K., Naughton, F., Leonardi-Bee, J., Sutton, S., Ussher, M., Leighton, M., Montgomery, A., Parrott, S., & Coleman, T. (2015) · Trials · doi:10.1186/s13063-014-0546-4 · Cited by 18
“A trial of nicotine patches found a 14% control group rate of self-reported, prolonged cessation between randomisation and 1 month [18], and control group women recruited to an exercise intervention RCT had a 13.”
BackgroundMethodSelf-citationNicotine treatment prolongs gestation and inhibits cervical ripening in pregnant rats
Yang, J., Shi, S.-Q., Shi, L., Liu, H., Fang, D., & Garfield, R. E. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.09.012 · Cited by 18
“Results from a nicotine patch replacement trial in humans also show that nicotine exposure increased the cesarean delivery rate, which suggests delayed cervical ripening.(5) At the cellular level, nicotine could induce the synthesis of type I collagen because some studies indicate that nicotine exposure increases derm…”
BackgroundAn update on the pharmacotherapeutic interventions for smoking cessation
Barboza, J., Patel, R., Patel, P. P., & Hudmon, K. S. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1197203 · Cited by 19
“There is some evidence from smaller trials that NRT use is safe and can show benefit in development for up to 2 years[50,51]; however, additional trials are warranted to confirm these findings.”
BackgroundGu, F., Deng, M., Gao, J. L., Wang, Z., Ding, C., Xu, Y., & Zhou, C. (2016) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-016-1077-7 · Cited by 19
“The z-score of each individual case was calculated using the following formula: “the weight of the individual child minus the median weight of a reference population of children born at the same gestational age and of the same gender divided by the standard deviation (at the same gestational age and the same gender)”…”
MethodKreyberg, I., Nordhagen, L. S., Bains, K. E. S., Alexander, J., Becher, R., Carlsen, K. H., Glavin, K., & Carlsen, K. C. L. (2019) · Acta Paediatrica · doi:10.1111/apa.14737 · Cited by 17
“Similarly, in the UK-based Smoking, Nicotine And Pregnancy trial conducted from 2007 to 2012 (22), no Table 1 Prevalence of snus during pregnancy”
BackgroundMethodFox, K. A., Longo, M., Tamayo, E. H., Gamble, P., Makhlouf, M. A., Mateus, J. F., & Saade, G. R. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.06.021 · Cited by 19
The Effect of E-Cigarette Taxes on Pre-pregnancy and Prenatal Smoking
Abouk, R., Adams, S., Feng, B., Maclean, J. C., & Pesko, M. F. (2019) · National Bureau of Economic Research · doi:10.3386/w26126 · Cited by 20
Marteau, T. M., Thorne, J., Aveyard, P. N., Hirst, J., & Sokal, R. (2013) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-13-66 · Cited by 18
“We estimate that about 30% of smokers approached will enrol, based on 45% recruitment rate in a “cessation induction” trial of incentives that used similar eligibility criteria, conducted in the US [14], and estimated 14% and 10% recruitment rates to two recent UK “aid to cessation” trials for pregnant women trying to…”
BackgroundDhalwani, N. N., Szatkowski, L., Coleman, T., Fiaschi, L., & Tata, L. J. (2019) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty019 · Cited by 15
Self-citationGetting over the shock: taking action on Indigenous maternal smoking
Gould, G. S., Cadet‐James, Y., & CLOUGH, A. R. (2016) · Australian Journal of Primary Health · doi:10.1071/py15066 · Cited by 15
“NRT is considered safe to use for the pregnant mother and foetus, according to the latest Cochrane review (Coleman et al. 2015).”
BackgroundMethodPedersen, L. H., Petronis, K. R., Nørgaard, M., Mo, J., Frøslev, T., Stephansson, O., Granath, F. N., Kieler, H., & Sørensen, H. T. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4894 · Cited by 15
“One previous study found that nicotine replacement therapy was associated with increased risk of congenital malformations in children born to nonsmoking mothers,(6) while several other studies found no association with risk of stillbirth or low birthweight.(2,7,8) Varenicline is a prescription aid for smoking cessatio…”
ResultComparison of nicotine dependence indicators in predicting quitting among pregnant smokers.
Kurti, A. N., Davis, D. R., Skelly, J. M., Redner, R. N., & Higgins, S. T. (2016) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000056 · Cited by 17
“As another example at the clinical level, nicotine replacement therapy is a staple of best practices for increasing smoking cessation rates among non-pregnant smokers (U.S. Public Health Service, 2008) whereas its efficacy in pregnant women is equivocal at best (e.g., Coleman et al., 2012).”
BackgroundKarelitz, J. L., McClure, E. A., Wolford‐Clevenger, C., Pacek, L. R., & Cropsey, K. L. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108570 · Cited by 16
Nicotine Replacement for Smoking Cessation during Pregnancy
Oncken, C. A. (2012) · New England Journal of Medicine · doi:10.1056/nejme1200136 · Cited by 17
Eades, S., Sanson‐Fisher, R., & Panaretto, K. S. (2013) · The Medical Journal of Australia · doi:10.5694/mja12.11298 · Cited by 14
What lessons have we learnt about the impact of maternal cigarette smoking from animal models?
Chan, Y. L., Oliver, B. G. G., & Chen, H. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13182 · Cited by 13
Kurti, A. N. (2019) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000342 · Cited by 13
Bergeria, C. L., Heil, S. H., Bunn, J. Y., Sigmon, S. C., & Higgins, S. T. (2017) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntx148 · Cited by 14
“smoking topography parameters, namely: (1) number of puffs per cigarette, (2) puff duration, (3) inter-puff interval, (4) puff volume and (5) maximum puff velocity.”
BackgroundMethodInfluentialTranslational toxicology: a developmental focus for integrated research strategies
Hughes, C. L., Waters, M. D., Allen, D., & Obasanjo, I. (2013) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-14-51 · Cited by 12
Przulj, D., Pesola, F., Smith, K. M., McRobbie, H. J., Coleman, T. J., Lewis, S., Griffith, C., Walton, R. T., Whitemore, R., Clark, E., et al. (2023) · Health Technology Assessment · doi:10.3310/agth6901 · Cited by 11
Self-citationSlaich, B., Claire, R., Emery, J. L., Lewis, S., Cooper, S. E., Thomson, R., Phillips, L., Kinahan‐Goodwin, D., Naughton, F., McDaid, L., et al. (2021) · Addiction · doi:10.1111/add.15671 · Cited by 11
“Unfortunately, only four paired exhaled CO samples were received when CO monitors were sent to participants for remote sample collection; however, it is probable these measurements were collected reliably, as participants were taught the correct processes [29,30].”
BackgroundSelf-citationWenner, F., & Goedken, J. A. (2012) · Postgraduate Obstetrics & Gynecology · doi:10.1097/01.pgo.0000419579.75781.7a · Cited by 10
Berlin, N., Goldzahl, L., Jusot, F., & Berlin, I. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011669 · Cited by 12
Essex, H. N., Parrott, S., Wu, Q., Li, J., Cooper, S., & Coleman, T. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntu258 · Cited by 9
Self-citationFan, J., Ping, J., Xiang, J., Rao, Y.-S., Zhang, W., Chen, T., Zhang, L., & Yan, Y. (2016) · Toxicology Research · doi:10.1039/c6tx00237d · Cited by 9
McDonnell, B. P., Dicker, P., Keogan, S., Clancy, L., & Regan, C. (2022) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2022.100763 · Cited by 11
Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches
Claire, R., Coleman, T. J., Leonardi‐Bee, J., & Berlin, I. (2019) · Addiction · doi:10.1111/add.14662 · Cited by 9
“Generally, in studies included in this review, such as the Smoking, Nicotine and Pregnancy (SNAP) trial, women were instructed to discontinue use of nicotine patches if they had even brief smoking lapses [15].”
BackgroundSelf-citationRaghunathan, R., Liu, C., Ambekar, Y. S., Singh, M., Miranda, R. C., & Larin, K. V. (2020) · Biomedical Optics Express · doi:10.1364/boe.394905 · Cited by 9
Iyen, B., Vaz, L. R., Taggar, J., Cooper, S. E., Lewis, S., & Coleman, T. J. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024923 · Cited by 8
“strengths and limitations Data for this study are from the largest randomised controlled trial of NRT in pregnancy in which participants, healthcare and research staff were masked to treatment allocation.(14) Follow-up and outcome ascertainment rates were high and there were only minor differences in characteristics o…”
BackgroundMethodInfluentialSelf-citationBlanc, J., & Koch, A. (2020) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2020.03.030 · Cited by 8
Developmental nicotine exposure alters cholinergic control of respiratory frequency in neonatal rats
Wollman, L., Haggerty, J., Pilarski, J. Q., Levine, R. B., & Fregosi, R. F. (2016) · Developmental Neurobiology · doi:10.1002/dneu.22380 · Cited by 8
“…deleterious effects of DNE on brain development and cardiorespiratory control in animal models discussed above, obstetricians routinely pre- scribe nicotine patches in pregnant, nicotine-addicted mothers (Coleman et al., 2012), with the intention of avoiding the other chemicals in tobacco smoke.”
BackgroundInfluentialUse of Pharmacotherapies for Smoking Cessation
Jarlenski, M., Chisolm, M. S., Kachur, S., Neale, D. M., & Bennett, W. L. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.10.019 · Cited by 7
Antiteratogenic Effects of β -Carotene in Cultured Mouse Embryos Exposed to Nicotine
Lin, C., Yon, J., Jung, A., Lee, J. G., Jung, K. Y., Lee, B. J., Yun, Y. W., & Nam, S.-Y. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/575287 · Cited by 11
Bastianini, S., Martire, V. L., Silvani, A., Zoccoli, G., Berteotti, C., Lagercrantz, H., Arner, A., & Cohen, G. (2017) · Acta Paediatrica · doi:10.1111/apa.14181 · Cited by 7
“Recommending NRT to pregnant or breast-feeding women as “safe and effective”, and calls to raise the current dosage regimen because it “does not work well enough” (14, 15) may also need to be reconsidered if NRT’s main by-product cotinine can be shown to have unrecognized adverse developmental side effects.”
BackgroundMa, E., Brown, N., Alshaikh, B. N., Slater, D. M., & Yusuf, K. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw271 · Cited by 7
Seifi, O. S. E., Younis, F. E., Mirza, I. M., Alhewiti, A., Abd-Elhady, N. M. S., & Mortada, E. M. (2025) · Healthcare · doi:10.3390/healthcare13070732 · Cited by 8
“When comparing the intervention group to the control group, the meta-analysis re-sults of fi ve studies [20,28,30,44,45] indicated no signi fi cant di ff erence in the rate of CS (RR: 1.06, 95% CI = 0.75–1.51, five studies [20,28,30,44,45] indicated no significant difference in the rate of CS (RR 95%…”
InfluentialNewspaper media representation of electronic cigarette use during pregnancy.
Moyse, M., & Hunter, A. (2020) · Journal of public health · doi:10.1093/pubmed/fdaa048 · Cited by 4
The effect of E‐cigarette indoor vaping restrictions on infant mortality
Cooper, M., & Pesko, M. F. (2022) · Southern Economic Journal · doi:10.1002/soej.12564 · Cited by 5
“A randomized control trial of roughly 1,000 pregnant women given real or placebo nicotine replacement therapy patches during pregnancy found some evidence that women given real nicotine replacement therapy patches during pregnancy had lower rates of smoking for up to two years after pregnancy (Coleman et al., 2012), a…”
BackgroundHughes, C. L. (2013) · Journal of Neonatal Biology · doi:10.4172/2167-0897.1000122 · Cited by 4
“[16] found no significant difference in the rate of abstinence from the quit date until delivery between the nicotinereplacement and placebo groups (9.”
BackgroundSmoking Cessation Guidelines in the Primary Care Setting
Noh, H., Paek, Y., & Lee, C. M. (2013) · Korean Journal of Family Practice · Cited by 4
Sevrage tabagique au cours de la grossesse
Peyronnet, V., Faou, A.-L. L., & Berlin, I. (2024) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2024.06.009 · Cited by 5
Mental Health and Behavioral Disorders in Pregnancy
Wisner, K. L., Sit, D. K. Y., Bogen, D. L., Altemus, M. M., Pearlstein, T. B., Svikis, D. S., Misra, D. P., & Miller, E. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-32108-2.00055-x · Cited by 5
Sevrage tabagique et grossesse
Underner, M., Pourrât, O., Perriot, J., Peiffer, G., & Jaafari, N. (2017) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2017.08.003 · Cited by 7
McMeekin, N., Sinclair, L., Bauld, L., Tappin, D. M., Mitchell, A. S., & Boyd, K. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038827 · Cited by 4
Smoking and Cellular Telephone Use Among Pregnant Women Seeking Prenatal Care
Gilbert, J., Schnoll, R. A., Morrison, M. F., Srinivas, S. K., Pond, T., Curtis, B. L., Henry, J., & Kranzler, H. R. (2014) · Addictive Disorders & Their Treatment · doi:10.1097/adt.0000000000000053 · Cited by 4
Nicotine-replacement therapy in pregnancy-the end of the road?
Koren, G. (2012) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e31826ab6c5 · Cited by 5
Pharmaceutical strategies for smoking cessation during pregnancy
Barboza, J. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1538353 · Cited by 4
“Coleman conducted a double-blind, placebo-controlled RCT evaluating the effect of nicotine patches 15 mg/16 for eight weeks compared to placebo on biochemically validated smoking cessation rates in pregnancy [38].”
MethodCost‐effectiveness of financial incentives for smoking cessation in pregnancy
Boyd, K., Tappin, D. M., & Bauld, L. (2016) · Addiction · doi:10.1111/add.13374 · Cited by 4
Weng, M., Ratsch, A., Miles, J. A., Zheng, Q., & Steadman, K. J. (2024) · Health Sciences Review · doi:10.1016/j.hsr.2024.100186 · Cited by 4
Efficacy of nicotine replacement therapy in pregnancy
Coleman, T. J., Chamberlain, C., Davey, M., Cooper, S. E., & Leonardi‐Bee, J. (2013) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12064 · Cited by 3
Self-citationClark, E., Cooper, S. E., Naughton, F., USSHER, M. H., Emery, J. L., McDaid, L., Thomson, R., Phillips, L., Bauld, L., Aveyard, P. N., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-087175 · Cited by 2
“23 However, compared with smoking, NRT has an apparently protective effect on infant development; at 2 years old, infants in the largest RCT of NRT in pregnancy, 24 born to women randomised to NRT rather than placebo, were more likely to have unimpaired development.”
BackgroundSelf-citationA Randomized Trial of Nicotine-Replacement Therapy Patches in Pregnancy
FRANCES, R. J. (2012) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/j.ypsy.2012.07.099 · Cited by 2
Berlin, I., Singleton, E. G., & Heishman, S. J. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.06.034 · Cited by 4
Rewarding smoking cessation in pregnancy‐will women cheat to gain incentives?
Bauld, L., & Sinclair, L. (2015) · Addiction · doi:10.1111/add.12851 · Cited by 2
Parental Smoking and Vascular Damage in Their 5-year-old Children
STOCKMAN, J. A. (2012) · Yearbook of Pediatrics · doi:10.1016/j.yped.2012.03.037 · Cited by 2
Boujenah, J. (2020) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2020.05.001 · Cited by 2
Campbell, K. A., Clark, E., Montgomery, A. A., Partlett, C., Dickinson, A., Bradshaw, L. E., Jones, M., Huang, Y., Aveyard, P. N., Jiang, Y., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-109568 · Cited by 1
Self-citationLovell, H., Wicks, E., Thompson, H., Brace, L., Stacey, T., Rayment‐Jones, H., & Harding, S. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-098926 · Cited by 1
The Opportunity to Translate Developmental Toxicology into a Therapeutic Discipline
Hughes, C. L., Waters, M. D., Allen, D., & Obasanjo, I. (2016) · Molecular and integrative toxicology · doi:10.1007/978-3-319-27449-2_1 · Cited by 1
Comparing smoking topography of usual brand cigarettes in pregnant and non-pregnant women
Bergeria, C. L., Heil, S. H., Sigmon, S. C., Durand, H., & Higgins, S. T. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.08.067 · Cited by 1
Smoking cessation during pregnancy and the potential role of exercise: A narrative review
Nagpal, T. S., Fagan, M. J., & Prapavessis, H. (2017) · Medical Research Archives · doi:10.18103/mra.v5i7.1413 · Cited by 1
Effects of In Utero Nicotine Exposure on Immune Cell Disposition After P. aeruginosa Lung Infection
Kang, N. (2017) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2017.351 · Cited by 2
“11 hours) to placebo during pregnancy concluded no significant benefit in increasing the rate of abstinence until delivery (38).”
BackgroundElectronic Cigarettes During Pregnancy: Another Tool for Discontinuing Smoking?
Selya, A., & Kim, S. (2024) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntae232 · Cited by 2
Drugs and Environmental Agents in Pregnancy and Lactation
Niebyl, J. R., Weber, R. J., & BRIGGS, G. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-32108-2.00008-1 · Cited by 4
“Ahora es momento de pensar en él”: Programa de ayuda a las gestantes para dejar de fumar.
Papiol, E. M. (2014) · RECERCAT (Consorci de Serveis Universitaris de Catalunya)
Matuskova, A. (2013) · OpenGrey (Institut de l'Information Scientifique et Technique)
Longo, C. A. (2013) · uO Research (University of Ottawa) · doi:10.20381/ruor-3391
A Randomized Trial of Nicotine-Replacement Therapy Patches in Pregnancy
SHULMAN, L. P. (2012) · Yearbook of Obstetrics Gynecology and Women s Health · doi:10.1016/j.yobg.2012.06.010
A Randomized Trial of Nicotine-Replacement Therapy Patches in Pregnancy
STOCKMAN, J. A. (2012) · Yearbook of Pediatrics · doi:10.1016/j.yped.2012.05.011
Nikotinplaster for røykeslutt under svangerskap?
Holtermann, M. K. (2012) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.12.0449
Making Smoking Cessation Stick: Nicotine-Replacement Patches in Pregnancy
Bryant, A. (2012) · Journal watch · doi:10.1056/wh201202290000001
Koren, G. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.07.021
Substance Use in Pregnancy: Managing the High-Risk Patient
Koren, G. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.07.020
Maternal Use of Other Psychoactive Drugs and Infant Congenital Malformations
Källén, B. A. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-17898-7_28
(2014) · Elsevier eBooks · doi:10.1016/b978-2-294-71330-9.00016-7
Vishwakarma, S. K., Puranik, M. P., & Shanbhag, N. (2021) · International Journal of Drug Research And Dental Science · doi:10.36437/ijdrd.2021.3.1.b
Polak, T. T., & Jacob, C. C. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_398-1
Kruszewski, J., Worobiej, D., Kolasińska, W., Sokołowski, R., & Rząd, M. (2021) · Advances in respiratory medicine · doi:10.5603/arm.a2021.0058
“The findings are actually contradictory [64, 65].”
Murff, H. J., Greevy, R. A., Sanghani, R. S., Hartmann, K. E., Hartert, T. V., Graves, C. R., Lee, S. S., & Tindle, H. A. (2021) · Trials · doi:10.1186/s13063-021-05865-7 · Cited by 1
Bernstein, L. B., Carson, M., Cruz, M., Harrison, R. K., Johnson, A., Kho, A., Lewis, B., & Tilstra, S. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-50695-7_39
Girnius, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-82464-4.00034-7
Polak, T. T., & Jacob, C. C. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_398
Use of Nicotine-Containing Products During Pregnancy: Effects on Fetal Development
Chun, J. (2024) · International STEAM Communications · doi:10.37906/isteamc.2024.1
Smoking Cessation During Pregnancy: An Evidence Based Practice Protocol
Ruhlman, K. J. (2015) · DigitalCommons-Cedarville (Cedarville University) · Cited by 2
Mersha, A. G., Eftekhari, P., Bovill, M., Tollosa, D. N., & Gould, G. S. (2021) · Figshare · doi:10.6084/m9.figshare.14167774
Mersha, A. G., Eftekhari, P., Bovill, M., Tollosa, D. N., & Gould, G. S. (2021) · Figshare · doi:10.6084/m9.figshare.14167777
Tabagismo e reposição de nicotina na gestação
Conceição, B. V. D., Arashiro, C. S., Souza, M. E. R. D., Zarichta, N., & Vettori, D. V. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Smoking and maternal health during pregnancy
Wallin, H. P. (2025) · UTUPub (University of Turku)
Thimkorn, P., Booncharoen, C., Chaipitak, P., Wiengkeaw, P., Thananithisak, C., Boonpattharatthiti, K., & Dhippayom, T. (2026) · Addictive Behaviors · doi:10.1016/j.addbeh.2026.108723
Jones, H. E., & Ramage, M. (2026) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2026.2756492
Factors influencing the relationship between socioeconomic status and prenatal smoking.
Yang, I. H. (2014) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/1620
“Coleman et al., 2012).”
Metadata
- Authors
- Coleman, T., Cooper, S., Thornton, J. G., Grainge, M. J., Watts, K., Britton, J., & Lewis, S.
- Affiliations
- University of Nottingham (GB)
- National Institute for Health and Care Research (GB)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-03
- Volume
- 366
- Issue
- 9
- Pages
- 808-818
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2132635946
- Semantic Scholar
- c5640a53023f2749177b54ed3b04e7193c716b47
- Cited by
- 190
- References
- 24
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 8 · 2021: 14 · 2020: 13 · 2019: 18 · 2018: 8 · 2017: 15 · 2016: 19 · 2015: 23 · 2014: 23 · 2013: 18 · 2012: 17
- FWCI
- 17.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Institute for Health and Care Research (06/07/01)
- Economic and Social Research Council (ES/G007489/1)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- nicotine replacement therapy, nicotine patch, smoking cessation, pregnancy, maternal smoking, birth outcomes, adverse pregnancy outcomes, exhaled carbon monoxide, salivary cotinine
- MeSH terms
- Administration, Cutaneous, Adult, Behavior Therapy, Cesarean Section, Double-Blind Method, Female, Follow-Up Studies, Humans, Nicotine, Pregnancy, Pregnancy Complications, Smoking Cessation, Medication Adherence, Tobacco Use Cessation Devices
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.